LITTLE FALLS, N.J., Sept. 19, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its fourth quarter ended July 31, 2013 on Thursday, September 26 before the market opens, and hold a conference call to discuss the results at 11:00 AM EDT. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO; Jorgen B. Hansen, Executive Vice President and COO; Craig A. Sheldon, Senior Vice President, CFO and Treasurer; and Seth Yellin, Senior Vice President-Corporate Development.
To participate in the conference call, dial (877) 407-8033 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, September 26, 2013 through midnight on November 26, 2013 by dialing (877) 660-6853 and using conference ID # 100313.
The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=171627. A replay of the webcast will be available for 90 days on Vcall and via the investor relations page of the Cantel web site.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at www.cantelmedical.com.
SOURCE Cantel Medical Corp.